Arcus Biosciences (RCUS) Earnings Date, Estimates & Call Transcripts → One trade. One ticker. One week. (From Wealthpin Pro) (Ad) Free RCUS Stock Alerts $15.43 -0.07 (-0.45%) (As of 04/24/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 8After Market ClosesConfirmedActual EPS (Feb. 21) -$1.08 Beat By $0.01 Consensus EPS (Feb. 21) -$1.09 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get Arcus Biosciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for RCUS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRCUS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RCUS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Insiders ExposedThe Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.Click To Access This Powerful Training Right Now! Arcus Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.72)($0.72)($0.72)Q2 20241($0.71)($0.71)($0.71)Q3 20241($0.74)($0.74)($0.74)Q4 20241($0.77)($0.77)($0.77)FY 20244($2.94)($2.94)($2.94)RCUS Earnings Date and InformationArcus Biosciences last posted its quarterly earnings data on February 21st, 2024. The reported ($1.08) EPS for the quarter, beating analysts' consensus estimates of ($1.09) by $0.01. The company earned $31 million during the quarter, compared to analysts' expectations of $28.30 million. Its revenue for the quarter was down 8.8% on a year-over-year basis. Arcus Biosciences has generated ($4.15) earnings per share over the last year (($4.15) diluted earnings per share). Earnings for Arcus Biosciences are expected to remain at ($3.59) per share in the coming year. Arcus Biosciences has confirmed that its next quarterly earnings report will be published on Wednesday, May 8th, 2024. Arcus Biosciences will be holding an earnings conference call on Wednesday, May 8th at 4:30 PM Eastern. Interested parties can register for or listen to the call.. Read More Arcus Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/8/2024Confirmed)------- 2/21/2024Q4 2023($1.09)($1.08)+$0.01($1.08)$28.30 million$31.00 million 11/7/2023Q3 2023($1.12)($0.94)+$0.18($0.94)$27.57 million$32.00 million 8/7/2023Q2 2023($1.10)($1.04)+$0.06($1.04)$31.81 million$29.00 million5/9/2023Q1 2023($1.06)($1.09)($0.03)($1.09)$22.47 million$25.00 million2/28/2023Q4 2022($0.99)($0.93)+$0.06($0.93)$23.43 million$34.00 million11/2/2022Q3 2022($1.05)($0.90)+$0.15($0.90)$18.26 million$33.58 million Get the Latest News and Ratings for RCUS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arcus Biosciences and its competitors with MarketBeat's FREE daily newsletter. 8/3/2022Q2 2022($0.93)($0.93)-($0.93)$21.00 million$26.76 million5/9/2022Q1 2022$0.83($0.96)($1.79)($0.96)$163.47 million$18.01 million2/23/2022Q4 2021($1.13)$3.71+$4.84$3.71$8.87 million$354.50 million11/8/2021Q3 2021($1.13)($1.11)+$0.02($1.11)$9.27 million$9.46 million8/4/2021Q2 2021($0.87)($1.09)($0.22)($1.09)$18.43 million$9.46 million 5/4/2021Q1 2021($0.86)($1.08)($0.22)($1.08)$18.80 million$9.46 million Arcus Biosciences Earnings - Frequently Asked Questions When is Arcus Biosciences's earnings date? Arcus Biosciences has confirmed that its next quarterly earnings data will be published on Wednesday, May 8th, 2024. Learn more on RCUS's earnings history. Did Arcus Biosciences beat their earnings estimates last quarter? In the previous quarter, Arcus Biosciences (NYSE:RCUS) reported ($1.08) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.09) by $0.01. Learn more on analysts' earnings estimate vs. RCUS's actual earnings. How can I listen to Arcus Biosciences's earnings conference call? The conference call for Arcus Biosciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Arcus Biosciences's conference call transcript? The conference call transcript for Arcus Biosciences's latest earnings report can be read online. Read Transcript How can I view Arcus Biosciences's earnings report? Arcus Biosciences's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Arcus Biosciences generate each year? Arcus Biosciences (NYSE:RCUS) has a recorded annual revenue of $117 million. How much profit does Arcus Biosciences generate each year? Arcus Biosciences (NYSE:RCUS) has a recorded net income of -$307 million. RCUS has generated -$4.15 earnings per share over the last four quarters. What is Arcus Biosciences's EPS forecast for next year? Arcus Biosciences's earnings are expected to stay at ($3.59) per share in the next year. More Earnings Resources from MarketBeat Related Companies: ZLAB Earnings Date KURA Earnings Date LGND Earnings Date MORF Earnings Date ANIP Earnings Date DVAX Earnings Date GYRE Earnings Date PTGX Earnings Date EWTX Earnings Date ARDX Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NYSE:RCUS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcus Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
